Browsing Tag

Special Reports

58 posts

DCAT Week ’17 Announcement Forum: CMC Biologics Updates Acquisition by AGC Asahi Glass
By

By
Robert Broeze, PhD Chief Business Officer CMC Biologics Robert Broeze, PhD, Chief Business Officer. CMC Biologics, outlined the operational focus for the company following the company’s acquisition by AGC Asahi…

DCAT Week ’17 Announcement Forum: Catalent Discusses Integration of Pharmatek and Accucaps Acquisitions
By

By
Elliott Berger Vice President, Global StrategyCatalent Pharma Solutions Elliott Berger, Vice President, Global Strategy, Catalent Pharma Solutions, highlighted the rationale and integration of two recent acquisitions by the company (Accucaps and…

DCAT Week ’17 Announcement Forum: BioVectra Outlines API Manufacturing Expansion
By

By
Marc SauerVice President, Research and DevelopmentBioVectra In 2017, BioVectra will complete its fourth GMP intermediate and active pharmaceutical ingredient (API) manufacturing facility in Atlantic Canada, outlined Marc Sauer, VIce President,…

Highlights from the Education Programs at DCAT Week ’17
By

By
From tracking pharmaceutical industry growth to evaluating sourcing and supply strategies for small molecules, biologics, and drug products, the DCAT Week ’17 education programs addressed a range of issues of…

Emerging Pharma: Boom or Bust for Pharma Partnering and Suppliers?
By

By
Emerging pharma companies are an important source of innovation for the pharmaceutical industry, but how is this sector performing, and what are the opportunities for partnering for larger pharma companies…

BMS, Pfizer, J&J, and Amgen Examine Best Practices in Sourcing and Procurement
By

By
How can pharmaceutical companies take sourcing, procurement, and supply management to the next level?. Pharmaceutical companies, contract development and manufacturing organizations (CDMOs), contract manufacturing organizations (CMOs), and suppliers are contending…

DCAT Week ’17: Pfizer, AstraZeneca, and Kite Pharma Discuss Biomanufacturing Strategy
By

By
As pharmaceutical companies intensify their product development in biologics, their supply requirements increase as well. The DCAT Week ’17 education program, Biomanufacturing 2027: Capacity, Investment, and Technology, gains insight from Pfizer,…

DCAT Week ’17: Next Generation Formulation and Drug Delivery Technologies
By

By
Pharmaceutical companies, CDMOs, CMOs, and excipient producers need to continually evaluate their strategies, technologies, and capabilities in formulation development, drug delivery, and drug-product manufacturing. How does your company’s toolbox measure…

DCAT Week ‘17: Are You Sending the Right Signals in Your Business Meetings?
By

By
Effective communication is an imperative for successful business relationships, but are you sending the right signals in your important meetings with customers, suppliers, colleagues, and management? In a special DCAT…

DCAT Week ’17: Pharma Outsourcing: On the Rise or Not?
By

By
Are pharmaceutical companies outsourcing more of their development and manufacturing activities, and what can be expected in 2017 and beyond? The DCAT Week ’17 education program, Pharma Outsourcing: The Numbers,…